Diabetic Peripheral Neuropathic Pain research hub
3 indexed studies · 3 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
A multicenter randomized, double-blind, placebo-controlled Phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult participants with chronic Diabetic Peripheral Neuropathic Pain (DPNP) / NEPTUNE-17.
This study is testing a new medicine, GSK3858279, for people with long-term nerve pain caused by diabetes. Researchers want to see if it helps reduce pain, is safe to use, and how it works in the body. Some people will get the medicine, and others a dummy treatment.
Spain · Germany · France - recruitingTherapeutic exploratory (Phase II)
A Double-blind, Randomized, Placebo-controlled, 4-arm Parallel-group, Multiple-Dose Study to Assess Efficacy and Safety of Medical Cannabis Aerosol via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain
This study tests whether inhaling medical cannabis through a special inhaler helps relieve nerve pain caused by diabetes. Researchers want to see if this treatment, used alongside regular medicines, safely lowers everyday pain and improves sleep compared to a dummy inhaler with no active medicine.
Poland · Czechia · Germany - recruitingPHASE2
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
This study is looking into a new medication called VX-993 for people who have pain from diabetic nerve damage (diabetic peripheral neuropathy). Researchers want to see if VX-993 can help reduce this pain and if it is safe to use. They will compare it to an existing drug and a dummy pill.
United States · Canada · France